• Consensus Rating: Hold
  • Consensus Price Target: $45.00
  • Forecasted Upside: 1,301.87%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.21
▲ +0.33 (11.46%)

This chart shows the closing price for CMAX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareMax Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CMAX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CMAX

Analyst Price Target is $45.00
▲ +1,301.87% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for CareMax in the last 3 months. The average price target is $45.00, with a high forecast of $60.00 and a low forecast of $30.00. The average price target represents a 1,301.87% upside from the last price of $3.21.

This chart shows the closing price for CMAX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 polled investment analysts is to hold stock in CareMax. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/20/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/18/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/18/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/17/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/15/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/12/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2024Jefferies Financial GroupReiterated RatingBuy ➝ HoldLow
11/17/2023UBS GroupDowngradeBuy ➝ Neutral$150.00 ➝ $30.00Low
11/10/2023Piper SandlerDowngradeOverweight ➝ Neutral$90.00 ➝ $60.00Low
3/17/2023TD CowenDowngradeOutperform ➝ Market Perform$210.00 ➝ $120.00Low
1/6/2023UBS GroupLower TargetBuy$300.00 ➝ $180.00Low
12/14/2022Piper SandlerLower Target$450.00 ➝ $150.00Low
11/16/2022CowenLower Target$210.00N/A
9/15/2022UBS GroupLower Target$330.00Low
9/7/2022Truist FinancialInitiated CoverageHold$225.00Low
5/17/2022UBS GroupLower TargetNA$360.00Medium
5/11/2022CowenLower Target$330.00 ➝ $240.00Low
5/11/2022CowenLower Target$330.00 ➝ $240.00High
1/7/2022UBS GroupInitiated CoverageBuy$420.00High
10/20/2021Jefferies Financial GroupInitiated CoverageBuy$450.00Medium
9/13/2021Piper SandlerUpgradeNeutral ➝ Overweight$420.00High
9/9/2021CowenInitiated CoverageOutperform$420.00High
7/1/2021Piper SandlerInitiated CoverageNeutral$420.00High
(Data available from 4/12/2019 forward)

News Sentiment Rating

-0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/15/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/15/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/14/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/14/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/13/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/12/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/13/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
4/12/2024

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Negative

  • No negative mentions tracked during this time.

Very Positive

CareMax logo
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.
Read More

Today's Range

Now: $3.21
Low: $2.88
High: $3.89

50 Day Range

MA: $6.04
Low: $2.88
High: $14.90

52 Week Range

Now: $3.21
Low: $2.75
High: $126.00

Volume

292,039 shs

Average Volume

78,529 shs

Market Capitalization

$12.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Frequently Asked Questions

What sell-side analysts currently cover shares of CareMax?

The following Wall Street sell-side analysts have issued stock ratings on CareMax in the last year: Jefferies Financial Group Inc., Piper Sandler, and UBS Group AG.
View the latest analyst ratings for CMAX.

What is the current price target for CareMax?

2 Wall Street analysts have set twelve-month price targets for CareMax in the last year. Their average twelve-month price target is $45.00, suggesting a possible upside of 1,405.0%. Piper Sandler has the highest price target set, predicting CMAX will reach $60.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $30.00 for CareMax in the next year.
View the latest price targets for CMAX.

What is the current consensus analyst rating for CareMax?

CareMax currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CMAX, but not buy more shares or sell existing shares.
View the latest ratings for CMAX.

What other companies compete with CareMax?

How do I contact CareMax's investor relations team?

CareMax's physical mailing address is 780 THIRD AVENUE 37TH FLOOR, NEW YORK NY, 10017. The company's listed phone number is 786-360-4768 and its investor relations email address is [email protected]. The official website for CareMax is www.caremax.com. Learn More about contacing CareMax investor relations.